Influenza virus infection causes highly contagious, severe respiratory disorders and gives rise to thousands of deaths every year; however, the efficacy of currently approved defense strategies, including vaccines and neuraminidase inhibitors, is limited because the virus frequently acquires resistance via antigen drift and reassortment. It is therefore important to establish a novel, effective therapeutic strategy that is effective irrespective of viral subtype.Here, we identify the Ras–phosphoinositide 3-kinase (PI3K) signaling pathway as a host-cell regulatory mechanism for influenza virus entry. The binding of Ras to PI3K is specifically involved in clathrin-independent endocytosis, endosomal maturation, and intracellular transport of v...
Influenza A virus (IAV) infection causes severe pulmonary disease characterized by intense leukocyte...
AbstractWe have previously shown that human papillomavirus virus-like particles (VLPs) are able to a...
Although annual influenza epidemics affect around 10% of the global population, current treatment op...
Endocytosis mediates the internalization and ingestion of a variety of endogenous or exogenous subst...
<div><p>Phosphoinositide-3-kinases have been shown to be involved in influenza virus pathogenesis. T...
Recent work has demonstrated that the PI3K (phosphoinositide 3-kinase) signalling pathway is importa...
The possible resistance of influenza virus against existing antiviral drugs calls for new therapeuti...
Host signaling pathways and cellular proteins play important roles in the influenza viral life cycle...
Influenza virus is a major human pathogen that causes annual epidemics and occasional pandemics. Mor...
The influenza A virus non-structural (NS1) protein is multifunctional, and during virus-infection NS...
Recently it has been shown by several laboratories that the influenza A virus nonstructural protein ...
The possible resistance of influenza virus against the existing antiviral drugs calls for new therap...
We generated influenza A viruses expressing mutant NS1 proteins unable to activate phosphoinositide ...
Respiratory viruses exert a heavy toll of morbidity and mortality worldwide. Despite this burden the...
Although annual influenza epidemics affect around 10% of the global population, current treatment op...
Influenza A virus (IAV) infection causes severe pulmonary disease characterized by intense leukocyte...
AbstractWe have previously shown that human papillomavirus virus-like particles (VLPs) are able to a...
Although annual influenza epidemics affect around 10% of the global population, current treatment op...
Endocytosis mediates the internalization and ingestion of a variety of endogenous or exogenous subst...
<div><p>Phosphoinositide-3-kinases have been shown to be involved in influenza virus pathogenesis. T...
Recent work has demonstrated that the PI3K (phosphoinositide 3-kinase) signalling pathway is importa...
The possible resistance of influenza virus against existing antiviral drugs calls for new therapeuti...
Host signaling pathways and cellular proteins play important roles in the influenza viral life cycle...
Influenza virus is a major human pathogen that causes annual epidemics and occasional pandemics. Mor...
The influenza A virus non-structural (NS1) protein is multifunctional, and during virus-infection NS...
Recently it has been shown by several laboratories that the influenza A virus nonstructural protein ...
The possible resistance of influenza virus against the existing antiviral drugs calls for new therap...
We generated influenza A viruses expressing mutant NS1 proteins unable to activate phosphoinositide ...
Respiratory viruses exert a heavy toll of morbidity and mortality worldwide. Despite this burden the...
Although annual influenza epidemics affect around 10% of the global population, current treatment op...
Influenza A virus (IAV) infection causes severe pulmonary disease characterized by intense leukocyte...
AbstractWe have previously shown that human papillomavirus virus-like particles (VLPs) are able to a...
Although annual influenza epidemics affect around 10% of the global population, current treatment op...